Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 Jun 03
With New Technology Comes Great Responsibility: Prostate-Specific Membrane Antigen Imaging in Recurrent Prostate Cancer.
Related Questions
Assume slowly rising PSA in a low risk prostate cancer patient with negative PSMA PET CT. If so, what dose and what would you cover? If not, when woul...
New answer by Radiation Oncologist at National Institutes of Health Clinical Center (February 8, 2024)
I would not offer further local therapy in this situation, especially given that there is no direct evidence of disease within a usual post-operative treatment field. I would ...